Mina K. Chung

Q: What Schools Are Affiliated With Mina K. Chung

Mina K. Chung is affiliated with the following schools: Ohio State University, Medical University of South Carolina, Icahn School of Medicine at Mount Sinai, University of Chicago, Case Western Reserve University, American University of Beirut, Massachusetts General Hospital, University of Rochester

Mina K. Chung's AcademicInfluence.com Rankings

Mina K. Chung

Medical

#3129

World Rank

#3584

Historical Rank

Cardiology

#316

World Rank

#326

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Mina K. Chung Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mina K. Chung's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (4204)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (2552)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (1864)
C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation (2001) (1366)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (1334)
Inflammation as a Risk Factor for Atrial Fibrillation (2003) (1330)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017) (1010)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017) (986)
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infa (2016) (866)
GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment (2013) (803)
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program (2019) (785)
Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry (2010) (558)
Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation (2001) (542)
Meta-analysis identifies six new susceptibility loci for atrial fibrillation (2012) (535)
2013 ACCF/AHA Guideline for the Management of ST‐Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (485)
Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation (2010) (454)
Genome-wide association study of PR interval (2010) (432)
Multi-ethnic genome-wide association study for atrial fibrillation (2018) (425)
A structural variation reference for medical and population genetics (2020) (394)
Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. (2013) (386)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary (2017) (345)
Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders (2013) (299)
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. (2010) (289)
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with (2011) (284)
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis (2020) (269)
Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. (2005) (265)
Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia. (2001) (262)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary (2017) (261)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. (2019) (261)
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). (2020) (260)
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). (2020) (254)
Stability over time of variables measuring heart rate variability in normal subjects. (1991) (248)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary (2017) (244)
Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation (2017) (243)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. (2017) (242)
Recovery of trait heritability from whole genome sequence data (2019) (223)
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. (2014) (219)
Cardioversion Guided by Transesophageal Echocardiography: The ACUTE Pilot Study: A Randomized, Controlled Trial (1997) (217)
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity A Scientific Statement From the American Heart Association (2018) (216)
Left Atrial Epicardial Adiposity and Atrial Fibrillation (2010) (197)
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Associat (2020) (196)
Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association (2017) (192)
Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. (2004) (189)
Stability over time of variables measuring heart rate variability in normal subjects (1991) (187)
Stability over time of variables measuring heart rate variability in normal subjects (1991) (187)
Stability over time of variables measuring heart rate variability in normal subjects (1991) (187)
Empirical Pulmonary Vein Isolation in Patients with Chronic Atrial Fibrillation Using a Three‐Dimensional Nonfluoroscopic Mapping System: Long‐Term Follow‐Up (2001) (186)
Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. (2005) (177)
Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation (2014) (177)
Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation (2013) (164)
His Bundle Pacing. (2018) (161)
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic (2020) (157)
Prevention of readmission in elderly patients with congestive heart failure (1993) (157)
Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? (1992) (154)
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association. (2020) (142)
Cardiovascular Implantable Electronic Device Replacement Infections and Prevention: Results from the REPLACE Registry (2012) (139)
Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. (2014) (137)
Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Associat (2020) (136)
Independent Susceptibility Markers for Atrial Fibrillation on Chromosome 4q25 (2009) (133)
Association of Left Atrial Endothelin-1 With Atrial Rhythm, Size, and Fibrosis in Patients With Structural Heart Disease (2010) (131)
Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. (1998) (127)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias (2019) (126)
Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator (2013) (125)
Cardiac surgery: Postoperative arrhythmias (2000) (124)
Plasma B-Type Natriuretic Peptide Levels and Recurrent Arrhythmia After Successful Ablation of Lone Atrial Fibrillation (2011) (123)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (114)
Atrial Glutathione Content, Calcium Current, and Contractility* (2007) (113)
Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation (2018) (106)
Effects of cocaine intoxication on the threshold for stun gun induction of ventricular fibrillation. (2006) (106)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2012) (105)
Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radiofrequency current. (1993) (102)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (101)
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy (2020) (100)
Cardiac Arrhythmias in COVID-19 Infection (2020) (100)
Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. (2004) (98)
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: executive summary this document was developed as a (2011) (97)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias (2019) (94)
Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole genome sequencing studies at scale (2020) (93)
Left Atrial Transcriptional Changes Associated With Atrial Fibrillation Susceptibility and Persistence (2015) (90)
Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. (2015) (89)
Transcript expression-aware annotation improves rare variant interpretation (2020) (89)
Atrial Fibrillation: JACC Council Perspectives. (2020) (87)
Evaluating drug targets through human loss-of-function genetic variation (2019) (86)
Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation. (2014) (83)
Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications. (1998) (82)
A Common Connexin-40 Gene Promoter Variant Affects Connexin-40 Expression in Human Atria and Is Associated With Atrial Fibrillation (2011) (81)
Ineffectiveness and potential proarrhythmia of atrial pacing for atrial fibrillation prevention after coronary artery bypass grafting. (2000) (80)
C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion (2005) (78)
Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals (2019) (78)
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. (2016) (76)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary (2019) (76)
Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. (2005) (72)
QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias. (2003) (72)
The effect of LRRK2 loss-of-function variants in humans (2020) (69)
The QRS Narrowing Index Predicts Reverse Left Ventricular Remodeling Following Cardiac Resynchronization Therapy (2011) (69)
Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries (2017) (68)
Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. (2004) (67)
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. (2020) (67)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (66)
Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation. (1999) (65)
Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies (2005) (64)
REDUCE-IT USA (2019) (63)
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary. (2014) (61)
PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity (2018) (61)
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. (2019) (60)
Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data (2022) (60)
Radiofrequency Ablation of Persistent Atrial Fibrillation: Diagnosis-to-Ablation Time, Markers of Pathways of Atrial Remodeling, and Outcomes (2016) (59)
Therapy Insight: interactions between atrial fibrillation and obstructive sleep apnea (2005) (59)
Left and right atrial transport function after the Maze procedure for atrial fibrillation: an echocardiographic Doppler follow-up study. (1997) (58)
Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology (2020) (57)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (2018) (56)
A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial (2012) (56)
Whole Genome Expression Differences in Human Left and Right Atria Ascertained by RNA Sequencing (2012) (55)
HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic (2020) (54)
Atrial Fibrillation Associated Chromosome 4q25 Variants Are Not Associated with PITX2c Expression in Human Adult Left Atrial Appendages (2014) (54)
Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model. (2011) (53)
Cybersecurity for Cardiac Implantable Electronic Devices: What Should You Know? (2018) (52)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (2018) (51)
QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy. (2013) (50)
PANCR, the PITX2 Adjacent Noncoding RNA, Is Expressed in Human Left Atria and Regulates PITX2c Expression (2016) (50)
Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy. (2008) (49)
Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin (2013) (47)
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies (2020) (46)
Vitamins, Supplements, Herbal Medicines, and Arrhythmias (2004) (45)
Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter. (2004) (44)
Three-dimensional mapping of the initiation of nonsustained ventricular tachycardia in the human heart. (1997) (44)
Machine Learning Prediction of Response to Cardiac Resynchronization Therapy. (2019) (43)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary (2020) (43)
Weighted Gene Coexpression Network Analysis of Human Left Atrial Tissue Identifies Gene Modules Associated With Atrial Fibrillation (2013) (43)
Safety and efficacy of radiofrequency energy catheter ablation of atrial fibrillation in patients with pacemakers and implantable cardiac defibrillators. (2005) (42)
Recurrent Atrial Fibrillation After Initial Long-Term Ablation Success: Electrophysiological Findings and Outcomes of Repeat Ablation Procedures (2018) (41)
The impact of age on the epidemiology of atrial fibrillation hospitalizations. (2014) (39)
Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial Fibrillation (2018) (39)
Prognosis of patients > or = 70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients > or = 70 years of age with Q-wave acute myocardial infarction. (1995) (38)
Atrial fibrillation early postoperatively following minimally invasive cardiac valvular surgery. (1999) (37)
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (2015) (37)
Cardiovascular Therapies Targeting Left Atrial Appendage. (2018) (35)
The role of the wearable cardioverter defibrillator in clinical practice. (2014) (35)
Do electrical stun guns (TASER-X26) affect the functional integrity of implantable pacemakers and defibrillators? (2007) (35)
Normalization of Left Ventricular Ejection Fraction after Cardiac Resynchronization Therapy Also Normalizes Survival (2013) (34)
Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice (2019) (33)
Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset. (2016) (33)
Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery. (2005) (33)
SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients (2020) (32)
Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans. (2016) (32)
Influence of Race on Atrial Fibrillation After Cardiac Surgery (2011) (32)
Effects of Extracorporeal Shock Wave Lithotripsy on Tiered Therapy Implantable Cardioverter Defibrillators (1999) (31)
Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes (2018) (29)
REPLACE DARE (Death After Replacement Evaluation) Score: Determinants of All-Cause Mortality After Implantable Device Replacement or Upgrade From the REPLACE Registry (2014) (29)
Termination of ventricular tachycardia in the human heart. Insights from three-dimensional mapping of nonsustained and sustained ventricular tachycardias. (1997) (29)
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic (2020) (28)
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic (2020) (28)
A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety (2015) (28)
Inflammation, Inflammasome Activation, and Atrial Fibrillation: Evidence for Causation and New Therapeutic Targets (2018) (26)
Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: Complexity, safety, and outcomes. (2017) (26)
Arrhythmogenic right ventricular cardiomyopathy: a cause of sudden death in young people. (2001) (25)
Clinical presentation of ventricular-Hisian and ventricular-nodal accessory pathways. (2019) (25)
Genomics of Atrial Fibrillation (2016) (25)
Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association (2021) (24)
Effectiveness of implantable cardioverter-defibrillator lead coil treatments in facilitating ease of extraction. (2010) (24)
Life-Threatening Complications of Atrial Fibrillation Ablation: 16-Year Experience in a Large Prospective Tertiary Care Cohort. (2018) (24)
Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Is Necessary at the Time of Implantable Cardioverter Defibrillator Implantation (2014) (23)
Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology (2020) (23)
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19 (2021) (23)
Impact of the COVID-19 Pandemic on Healthcare Workers’ Risk of Infection and Outcomes in a Large, Integrated Health System (2020) (22)
Matching Approved “Nondedicated” Hardware to Obtain Biventricular Pacing and Defibrillation: Feasibility and Troubleshooting (2002) (22)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary. (2020) (21)
New hope for the prevention of recurrent atrial fibrillation. (2004) (20)
Common Coding Variants in SCN10A Are Associated With the Nav1.8 Late Current and Cardiac Conduction (2018) (20)
Left ventricular diastolic dysfunction in lone atrial fibrillation determined by Doppler tissue imaging of mitral annular motion. (2000) (19)
Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation (2020) (19)
Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks’ Gestational Age: A Randomized Clinical Trial (2018) (19)
Atrial fibrillation, sleep apnea and obesity (2004) (18)
QRS Fragmentation Is Not Associated with Poor Response to Cardiac Resynchronization Therapy (2011) (18)
Machine Learning of 12-Lead QRS Waveforms to Identify Cardiac Resynchronization Therapy Patients With Differential Outcomes (2020) (18)
Machine Learning–Based Risk Assessment for Cancer Therapy–Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients (2020) (18)
Pacing the right ventricle: to pace or not to pace? (2005) (18)
Catheter ablation of an unusual decremental accessory pathway in the left coronary cusp of the aortic valve mimicking outflow tract ventricular tachycardia. (2012) (18)
Intraoperative electro-anatomical mapping and beating heart ablation of ventricular tachycardia. (2006) (17)
Applications of machine learning in decision analysis for dose management for dofetilide (2019) (16)
Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation? (2013) (16)
Atrial pacing in the prevention of atrial fibrillation after cardiac surgery: results of the second post operative pacing study (POPS-2) (1998) (16)
Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review (2018) (16)
Left Ventricular Hypertrophy and Antiarrhythmic Drugs in Atrial Fibrillation: Impact on Mortality (2010) (16)
Randomized Trials of Rate vs. Rhythm Control for Atrial Fibrillation (2004) (16)
Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium (2017) (15)
New Model of Automated Patient-Reported Outcomes Applied in Atrial Fibrillation (2019) (15)
Gene-gene Interaction Analyses for Atrial Fibrillation (2016) (14)
Impact of the COVID-19 pandemic on healthcare workers risk of infection and outcomes in a large, integrated health system. (2020) (14)
Atrial fibrillation increases length of stay and cost after cardiac surgery in low risk patients targeted for early discharge (1996) (14)
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results (2020) (14)
Preload-adjusted maximal power: a novel index of left ventricular contractility in atrial fibrillation (2002) (14)
Atrial Tachyarrhythmias Among Patients With Left Ventricular Assist Devices: Prevalence, Clinical Outcomes, and Impact of Rhythm Control Strategies. (2019) (12)
Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation (2019) (12)
Atrial fibrillation: rate control is as good as rhythm control for some, but not all. (2003) (12)
Machine Learning–Derived Fractal Features of Shape and Texture of the Left Atrium and Pulmonary Veins From Cardiac Computed Tomography Scans Are Associated With Risk of Recurrence of Atrial Fibrillation Postablation (2021) (11)
Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendage (2021) (11)
Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery. (2013) (11)
Cardiac risk stratification in cancer patients: A longitudinal patient–patient network analysis (2021) (10)
Catheter Ablation in Patients With Cardiogenic Shock and Refractory Ventricular Tachycardia (2020) (10)
HRS Clinical Document Development Methodology Manual and Policies: Executive summary. (2017) (10)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias (2020) (10)
Cardiac Venous Injuries: Procedural Profiles and Outcomes during Left Ventricular Lead Placement for Cardiac Resynchronization Therapy. (2020) (10)
Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association. (2022) (10)
Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System (2021) (10)
Current clinical issues in atrial fibrillation. (2003) (10)
Omega-3 fatty acid supplementation for the prevention of arrhythmias (2008) (10)
Management of atrial flutter. (2001) (10)
Abstract 13128: Use of Dabigatran for Peri-Procedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial fibrillation: A New Paradigm in Peri-Procedural Anticoagulation (2011) (9)
Repeat ablation or medical management alone for recurrent arrhythmias after ablation of persistent atrial fibrillation (2018) (9)
Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology (2020) (9)
Proarrhythmic effects of post-operative pacing intended to prevent atrial fibrillation: evidence from a clinical trial. (2003) (9)
Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling. (2020) (9)
Safety of Catheter Ablation for Atrial Fibrillation in Patients With Prior Cerebrovascular Events. (2016) (9)
A new machine learning approach for predicting likelihood of recurrence following ablation for atrial fibrillation from CT (2021) (9)
Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity. (2012) (9)
Management of Arrhythmias After Heart Transplant (2021) (9)
Multicenter Analysis of Dosing Protocols for Sotalol Initiation (2019) (8)
Is defibrillation testing necessary? (2014) (8)
Digital Health and the Care of the Patient With Arrhythmia (2020) (8)
Noninvasive voltage and activation mapping of ARVD/C using ECG imaging. (2013) (8)
Sleep apnea screening instrument evaluation and novel model development and validation in the paroxysmal atrial fibrillation population (2020) (7)
HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic (2020) (7)
Abstract 4403: Significant Single Nucleotide Polymorphism Associated with Atrial Fibrillation Located on Chromosome 4q25 in a Whole Genome Association Study and Association with Left Atrial Gene Expression (2008) (7)
Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk. (2021) (7)
Safety of Oral Dofetilide Reloading for Treatment of Atrial Arrhythmias (2017) (7)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? (2018) (7)
Task Force on Practice Guidelines A Report of the American College of Cardiology Foundation/American Heart Association 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: (2014) (7)
Arrhythmias in Cardiac Sarcoidosis Bench to Bedside (2021) (7)
Discovering patterns of pleiotropy in genome-wide association studies (2018) (7)
An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels (2018) (7)
Reduced Cardioversion Thresholds for Atrial Fibrillation and Flutter Using the Rectilinear Biphasic Waveform (2005) (7)
Left atrial appendage ligation during mitral valve surgery may increase the risk of late thromboembolic events (2002) (7)
Shared Decision-Making in Cardiac Electrophysiology Procedures and Arrhythmia Management. (2021) (7)
Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology (2020) (7)
Atrial fibrillation future clinic. Novel platform to integrate smart device electrocardiogram into clinical practice (2021) (6)
Occupational and patient radiation doses in a modern cardiac electrophysiology laboratory (2018) (6)
Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma. (2019) (6)
Selecting antithrombotic therapy for patients with atrial fibrillation (2015) (6)
Internal cardioversion of atrial fibrillation using standard ventricular implantable cardioverter-defibrillators (1998) (6)
COVID-19 and Cardiac Arrhythmias: a Contemporary Review (2022) (5)
Postoperative atrial fibrillation. (1997) (5)
WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation (2017) (5)
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation (2022) (5)
Low prevalence of connexin-40 gene variants in atrial tissues and blood from atrial fibrillation subjects (2012) (5)
Positive Airway Pressure-Induced Conversion of Atrial Fibrillation to Normal Sinus Rhythm in Severe Obstructive Sleep Apnea. (2016) (5)
Strategies for stroke prevention in atrial fibrillation. (2005) (5)
Drug Interactions Affecting Oral Anticoagulant Use (2022) (5)
TEE-guided anticoagulation in patients undergoing electrical cardioversion of atrial fibrillation: results from the ACUTE registry (1998) (5)
Arrhythmias in Female Patients: Incidence, Presentation and Management. (2022) (5)
C-Reactive protein level and recurrence of atrial fibrillation after electrical cardioversion (2005) (5)
Digital Health and the Care of the Arrhythmia Patient; What Every Electrophysiologist Needs to Know. (2020) (5)
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic (2020) (4)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary (2020) (4)
Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial (2022) (4)
Axillary vein puncture access causes a unique lead failure mechanism (2005) (4)
Ablation of Atrial Fibrillation Without Left Atrial Appendage Imaging in Patients Treated With Direct Oral Anticoagulants (2020) (4)
Abstract 3873: Episodes of Anger Trigger Ventricular Arrhythmias in Patients with Implantable Cardioverter Defibrillators (2006) (4)
Year in Review in Cardiac Electrophysiology (2018) (4)
Should patients receive anticoagulation for paroxysmal atrial fibrillation? (2000) (4)
The Role of the Wearable Cardioverter-Defibrillator In Contemporary Clinical Practice (2011) (3)
High infusion rate of isoproterenol in patients with atrial fibrillation: frequent evidence of firing from multiple veins (2002) (3)
Antithrombotic Treatment and Cardioversion of Patients with Atrial Fibrillation (2008) (3)
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers (2020) (3)
Validating and implementing cardiac telemetry for continuous QTc monitoring: A novel approach to increase healthcare personnel safety during the COVID-19 pandemic (2021) (3)
Myocardial compliance was not altered after acute induction of atrial fibrillation in sheep. (2005) (3)
Hydration versus N-acetylcysteine for protection of renal function in patients with renal insufficiency undergoing percutaneous coronary intervention (2003) (3)
Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) (3)
Racial and ethnic disparities in arrhythmia care: A call for action. (2022) (3)
Electromagnetic Interference and Cardiac Implantable Electronic Devices: Is the Ride in Electric Cars Still Cool? (2019) (3)
Multi-ethnic genome-wide association study for atrial fibrillation (2018) (3)
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte P-adrenergic responsiveness (3)
Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator (2020) (3)
Risk factor modification: another win for our fight against atrial fibrillation. (2019) (3)
Management of Congenital Long-QT Syndrome: Commentary From the Experts (2021) (2)
Cardioversion failure vs success: Impact of obesity and antiarrhythmic drugs (2005) (2)
Abstract 1385: Prevalence of Anxiety and Type D Personality in an Outpatient ICD Clinic (2009) (2)
Incidence and Predictors of 30-day Acute Cerebrovascular Accidents Post Atrial Fibrillation Catheter Ablation (From the Nationwide Readmissions Database). (2020) (2)
Reply: Cyberattacks and Cardiac Devices: Firmware Patches Are Not Vaccinations! (2018) (2)
Imaging of Implantable Devices (2011) (2)
Improvement of ventricular function following catheter ablation of frequent ventricular arrhythmias (2003) (2)
Abstract 2435: Charlson Comorbidity Index and Risk of Cardiac Rhythm Device Generator Replacement: Results From the REPLACE Registry (2009) (2)
A Cross-Center Virtual Education Fellowship Program for Early-Career Researchers in Atrial Fibrillation. (2020) (2)
Insights From Atrial Fibrillation Genomics: From Bedside to Bench and Back Again. (2019) (2)
Response to Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al. (2013) (2)
Abstract 9816: Use of the Wearable Cardioverter Defibrillator and Survival After Coronary Artery Revascularization in Patients with Left Ventricular Dysfunction (2011) (2)
Proarrhythmic effects from competitive atrial pacing and potential programming solutions (2020) (2)
Catheter Ablation for Rate-Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment. (2017) (2)
Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association. (2021) (2)
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation (2017) (2)
P1-87:Validation of an institutionally accepted standardization of the coronary sinus tributaries and left ventricular myocardial segments (2006) (2)
Drug Interactions Affecting Antiarrhythmic Drug Use (2022) (2)
Attenuated heart rate recovery is associated with higher arrhythmia recurrence and mortality following atrial fibrillation ablation. (2021) (2)
Advanced age and left atrial enlargement predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery (1996) (2)
The ENHANCE-AF Clinical Trial to Evaluate an Atrial Fibrillation Shared Decision-Making Pathway: Rationale and Study Design. (2022) (2)
Arrhythmias and cognitive function. (2018) (2)
Acute Myocardial Infarction-Like Events in Related Patients With a Desmoplakin-Associated Arrhythmogenic Cardiomyopathy (2021) (2)
B-type natriuretic peptide predicts recurrence of atrial fibrillation after pulmonary vein antral isolation (2005) (1)
Imaging and atrial fibrillation: A new paradigm for precision targeting of AF? (2019) (1)
Abstract 2906: Effectiveness of New ICD Lead Coil Treatments in Facilitating Ease of Extraction (2009) (1)
Abstract 8221: Cis Regulation of Genes in Human Atria Near SNPs Associated with Atrial Fibrillation and PR Interval (2011) (1)
The Spectranetics laser Sheath Reduces Extraction Time for Nonthoracotomy Defibrillator Leads (1998) (1)
Genome-wide association meta-analysis of PR interval identifies 47 novel loci associated with atrial and atrioventricular electrical activity (2018) (1)
22 – Prevention of Sudden Cardiac Death (2017) (1)
Ascorbate attenuates atrial pacing-induced peroxynitrite formation, electrical remodeling and the incidence of post-operative atrial fibrillation (2002) (1)
Angiotensin-Converting Enzyme Inhibitors vs Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients with Coronavirus Disease 2019 (COVID-19). (2020) (1)
813-2 Mitral Valvuloplasty Combined with the Maze Procedure (1995) (1)
There is power in numbers--even/especially in genomic medicine. (2012) (1)
PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity (2018) (1)
ABLATION OF ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2015) (1)
P1-15: The role of T-cells as inflammatory mediators in perpetuation of atrial fibrillation (2006) (1)
Abstract 14183: Some Like It Cool - Seasonal Temperature, as Well as Clinical And Demographic Factors, Predicts Compliance With the Wearable Cardioverter Defibrillator (2011) (1)
1003-2 Left and Right Atrial Systolic Function After the Maze Procedure: A Long-term Echo-Doppler Follow-up Study (1995) (1)
Do age and postoperative atrial fibrillation explain temporal trends in mortality and stroke after cardiac surgery (1996) (1)
Emerging role of artificial intelligence in cardiac electrophysiology (2022) (1)
Abstract 2434: Replacement of Cardiac Rhythm Devices: Is the Risk Different When Performed by Trained Electrophysiologists, in Academic or Private Practice? Results From the REPLACE Registry (2009) (1)
Publisher Correction: Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries (2018) (1)
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19 (2020) (1)
Mitigating Post-Extraction Risk: Is it Worth the inVESTment? (2017) (1)
Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway (2022) (1)
Abstract 19189: Long-term Outcomes of Catheter Ablation of Atrial Fibrillation in Elderly Patients (2015) (1)
Sex-Specific Electrophysiologic Properties (2014) (1)
ATTENUATED HEART RATE RECOVERY IS ASSOCIATED WITH HIGHER ARRHYTHMIA RECURRENCE AND MORTALITY FOLLOWING ATRIAL FIBRILLATION ABLATION (2021) (0)
Abstract 14305: Functional Genomics Implicates Decreased Fam13B Expression as Causal for the Chromosome 5q31 Atrial Fibrillation Risk Locus (2016) (0)
Abstract 19205: Prognostic Value of Overnight Holter Monitor Post Pulmonary Vein Isolation (2016) (0)
Impact of dietary fish oil on the atrial endothelin system and inositol triphosphate signaling: relevance to post‐operative atrial fibrillation (2010) (0)
P6-57: Utility of isochronal maps using the CARTO system in mapping the distribution of fractionated electrograms in the left atrium during atrial fibrillation (2006) (0)
Abstract 15509: SYNE2 Expression Regulates Calcium Cycling and Mitochondria Function in Cardiomyocytes: Implications for Association With Atrial Fibrillation (2020) (0)
911–31 Cardiac Surgery Results in Changes of Atrial Refractoriness that may Explain Vulnerability to Postoperative Atrial Fibrillation (1995) (0)
Abstract 11237: Expression of Mitochondrial, Contractile, and Calcium Regulatory Proteins is Altered in Patients with Atrial Fibrillation (2021) (0)
Is age an independent predictor of mortality in patients with acute myocardial infarction (1991) (0)
REGULATION OF PLASMA ET-1 LEVELS BY CHROMOSOME 4Q25 SNP ASSOCIATED WITH ATRIAL FIBRILLATION (2010) (0)
Atrial fibrillation (multiple letters) (2003) (0)
Abstract 16843: Black Race is Linked to Lower Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery (2010) (0)
798-4 Predictors of the Efficacy of Sotalol, a Class III Antiarrhythmic Agent, in the Treatment of Atrial Arrhythmias (1995) (0)
Mechanisms of ventricular tachycardia termination in the human heart (1996) (0)
Abstract 3182: Optimal Timing for Initiation of Cardiac Resynchronization Therapy with Left Ventricular Epicardial Pacing Leads (2006) (0)
0614 Diurnal Patterning of Autonomic Measures in Sleep Apnea and Paroxysmal Atrial Fibrillation and Response to Continuous Positive Airway Pressure Therapy (2020) (0)
1148-223 Robust long-term cardiac monitoring using dry, nonadhesive capacitive electrodes (2004) (0)
Abstract 20782: Incidence and Predictors of Postoperative Atrial Fibrillation in Patients Undergoing Elective Noncardiac Surgery in a large cohort of patients (2010) (0)
Abstract 15778: Functional Genomics at the SYNE2 Gene Locus Associated With Atrial Fibrillation (2018) (0)
ANNUAL REVIEWERS LIST (2009) (0)
P4-28: Evidence of phagocytosis and oxidative injury in left atrial appendage of patients with atrial fibrillation (2006) (0)
P6-86: Cardiac vulnerability to ventricular fibrillation during electrical stun gun (TASER-X26) application: Effect of cocaine intoxication (2006) (0)
Abstract 18086: Psychometric Testing and Shocks in Patients with Implantable Cardioverter Defibrillators (2012) (0)
Syncope Events, Definitions, Causes, and Features (2020) (0)
Impact of reductions in Medicare reimbursement for cardiac ablation in the United States: Heart Rhythm Society's follow-up survey. (2023) (0)
SAFETY OF ORAL DOFETILIDE RELOADING COMPARED TO INITIAL LOADING FOR TREATMENT OF ATRIAL ARRHYTHMIAS (2015) (0)
Abstract 9714: The Impact of Chronic Kidney Disease on Complications and All-Cause Mortality After Implantable Device Replacement or Upgrade: Survival Analyses From the REPLACE Registry (2012) (0)
Machine Learning Prediction of Pericardial Tamponade After Atrial Fibrillation Ablation. (2022) (0)
Abstract 12133: Survival in the Elderly Undergoing Cardiac Resynchronization Therapy (2010) (0)
Significant risk for ventricular arrhythmias remains after partial left ventriculectomy (1998) (0)
Chemokine receptor CXCR4 is upregulated in human atrial fibrillation (2005) (0)
Does advanced age itself predict outcome after infarction (1992) (0)
Abstract 8680: Long Term Outcomes in Patients with Borderline Prolonged QRS Durations Following Cardiac Resynchronization Therapy (2011) (0)
Comprar Arrhythmia Essentials | Brian Olshansky | 9780763774769 | Jones & Bartlett Publishers (2011) (0)
Usefulness of plasma BNP to determine responders and non-responders of cardiac resynchronization therapy (2005) (0)
Atrial mechanical function and eight-week clinical outcomes in patients with atrial flutter undergoing electrical cardioversion: results from the ACUTE clinical trial (2002) (0)
N-Acetylcysteine and Postoperative Atrial Fibrillation: Reply. (2022) (0)
Impact of Obesity on Catheter Ablation of Atrial fibrillation: Patient Characteristics, Procedural Complications, Outcomes and Quality of Life (2023) (0)
REDUCE-IT: accumulation of data across prespecified interim analyses to final results (2020) (0)
Abstract P382: Transcriptomic Analysis Of Human Left Atrial Tissue Reveals Mitochondrial Gene Co-expression (2021) (0)
PO-630-02 THE EFFECT OF CHANGES IN EXTRACELLULAR CALCIUM ON THE SMALL-CONDUCTION CA2+-ACTIVATED K+ CHANNEL OF METABOLIC SYNDROME (2022) (0)
B-PO05-201 IMMEDIATE RECURRENCE OF ATRIAL FIBRILLATION AS A PREDICTOR OF LONG TERM ATRIAL FIBRILLATION RECURRENCE FOLLOWING DIRECT CURRENT CARDIOVERSION (2021) (0)
Survival after cardiac resynchronization therapy. Evidence for inflammation as a predictor of mortality in patients with heart failure after bi-ventricular device implantation (2005) (0)
Abstract 470: Computational Identification of NKX2-5 Binding Sites and Downstream Gene Targets Using Transcription Factor Motif and Human Heart-specific Experimental Data (2016) (0)
Boldly Going Where Few Have Gone Before: The Voyages of Cardiac Catheter Ablation. (2017) (0)
Abstract 4410: A Novel and Common Insertion/Deletion Polymorphism in the GJA5 Gene Encoding Connexin-40 Is Associated with Connexin-40 Expression in Human Atrial Tissue (2008) (0)
Will elderly non-Q-wave infarction patients benefit from an aggressive approach? (1996) (0)
B-PO04-112 IMPACT OF SLEEP APNEA DIAGNOSIS AND TREATMENT IN MORBIDLY OBESE PATIENTS ON AF RECURRENCE AFTER ABLATION (2021) (0)
Syncope Management and Diagnostic Testing (2020) (0)
Abstract 9632: Mitral Regurgitation and Atrial Fibrillation: Is it Worth Cardioverting? (2013) (0)
C-Reactive Protein Elevation in Patients With Atrial Arrhythmias Inflammatory Mechanisms and Persistence of Atrial Fibrillation Clinical Investigation and Reports (2001) (0)
Erratum: Aggregate national experience with the wearable cardioverter- defibrillator: Event rates, compliance, and survival (Journal of the American College of Cardiology (2010) 56 (194-203)) (2011) (0)
B-PO04-082 ELECTROPHYSIOLOGICAL FINDINGS UNDERLYING RECURRENT ATRIAL TACHYARRHYTHMIAS AFTER SURGICAL ATRIAL FIBRILLATION ABLATION IN THE ERA OF HIGH DENSITY MAPPING (2021) (0)
The Prevalence of Atrial Fibrillation in Patients with Congestive Heart Failure and Hypogammaglobulinemia (2007) (0)
1154-92 Compliance and effectiveness of the wearable cardioverter defibrillator vest (2004) (0)
Abstract 5924: Epicardial vs. Coronary Sinus Lead Placement for Cardiac Resynchronization Therapy in the Treatment of Heart Failure (2008) (0)
STROKE RISK IN POST-MENOPAUSAL WOMEN WITH ATRIAL FIBRILLATION IN THE WOMEN'S HEALTH INITIATIVE: A VALIDATION AND COMPARISON OF THE CHADS2 AND CHA2DS2-VASC RISK SCORES (2012) (0)
Radiation exposure during electrophysiology procedures : results from the EPIC global survey (2012) (0)
Relation of gender on risk of arrhythmia requiring therapy from an implantable defibrillator (2005) (0)
1034-211 Neutrophil infiltration as an inflammatory mechanism promoting atrial fibrosis in atrial fibrillation (2004) (0)
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. (2023) (0)
B-PO04-118 EARLY ABLATION OF VENTRICULAR TACHYCARDIA IS ASSOCIATED WITH IMPROVED OUTCOMES (2021) (0)
Abstract 262: Regional Transcriptomics of Left Atrial Cardiac Tissue in a Patient With Atrial Fibrillation (2020) (0)
High predictive value of paced QRS frequency in verification of left bundle branch pacing. (2023) (0)
1146-106 Does abatement of ventricular ectopy with exercise mean a better prognosis? (2004) (0)
Lifestyle Changes in Atrial Fibrillation Management and Intervention. (2023) (0)
Evidence of inflammatory and hemodynamic remodeling after biventricular device implantation for heart failure (2005) (0)
911-32 Atrial Conduction Latency Predicts Occurrence of Post Operative Atrial Fibrillation in Patients Undergoing Coronary Bypass Surgery (1995) (0)
Causal SNP regulating FAM13B expression identified for the Chr. 5q31 atrial fibrillation susceptibility locus (2019) (0)
Commentary on: Pericardial Fat is Independently Associated with Human Atrial Fibrillation by Al Chekakie et al. (2010) (0)
Cardiac Pericytes (2023) (0)
Abstract 1781: Enriched Association of Chromosome 4q25 Locus With Lone Atrial Fibrillation Patients Showing Dissociated Firing After Pulmonary Vein Isolation (2009) (0)
Elucidating Influence of Underlying Pulmonary Physiology in the Association of Sleep-Related Hypoxemia and Incident Atrial Fibrillation (2023) (0)
Atrial fibrillation associated common risk variants in SYNE2 lead to lower expression of nesprin-2α1 and increased nuclear stiffness (2019) (0)
Guidelines on diagnosis and conduct of syncope (version 2009) (2009) (0)
P-493 Are EP studies still useful in the post-madit II era? (2003) (0)
Reply to Di Donato and colleagues (2007) (0)
Inflammation predicts incident atrial fibrillation: insight from the Cardiovascular Health Study (2002) (0)
QRS duration is a strong predictor of mortality in patients undergoing electrophysiologic studies (2002) (0)
Abstract 13210: Left Atrial Global Longitudinal Strain in the Prediction of Sinus Rhythm Maintenance after Catheter Ablation for Atrial Fibrillation (2012) (0)
Abstract 11214: Ibrutinib Decreases Mitochondrial Oxidative Phosphorylation and Metabolic Gene Expression in Atrial-Like Engineered Heart Tissue (2021) (0)
Therapeutic End 10100 Ar the Tr eentrant rachycannv oy Catheter-G - Ade (2016) (0)
Abstract 14523: N-acetylcysteine for the Prevention of Atrial Fibrillation After Noncardiac Thoracic Surgery: A Double-blind, Randomized, Placebo-controlled Trial (2020) (0)
Inflammation as a cause and consequence of atrial fibrillation (2003) (0)
Abstract 11461: A Prospective Study of Anxiety in ICD Patients With Randomized Controlled Pilot Trial of Cognitive Behavioral Therapy for Moderate to Severe Anxiety (2014) (0)
In reply: Atrial fibrillation (June 2003) (2003) (0)
MACHINE LEARNING PREDICTION OF ECHOCARDIOGRAPHIC RESPONSE AND SURVIVAL IN CARDIAC RESYNCHRONIZATION THERAPY (2019) (0)
New Radiomic Markers of Pulmonary Vein Morphology Associated With Post-Ablation Recurrence of Atrial Fibrillation (2022) (0)
B-PO05-002 DIFFERENTIAL GENE EXPRESSION BY AGE AND ATRIAL FIBRILLATION IN THE HUMAN LEFT ATRIUM (2021) (0)
How do female electrophysiologists deal with radiation exposure during pregnancy : Results from the EPIC global survey (2012) (0)
BS-515-04 REPLICATED GENE EXPRESSION CHANGES IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION (2022) (0)
GENETIC, BUT NOT CONVENTIONAL RISK FACTORS PREDICT RISK OF STROKE OR TRANSIENT ISCHEMIC ATTACK IN LONE ATRIAL FIBRILLATION (2010) (0)
Abstract 14106: The Efficacy of Sodium Glucose Co-transporter 2 Inhibitors in Atrial Fibrillation: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2020) (0)
Electrical prediction of postoperative atrial fibrillation from continuous recordings of atrial electrograms (1998) (0)
Abstract 1965: Common Variants in KCNN3 Are Associated With Early-Onset Atrial Fibrillation (2009) (0)
Postoperative Myocardial Infarction and In-Hospital Mortality Predictors in Patients Undergoing Elective Noncardiac Surgery (2010) (0)
Outcomes of Conduction System Pacing for Cardiac Resynchronization Therapy in Patients with Heart Failure: A Multicenter Experience. (2023) (0)
Abstract 2164: Right Ventricular Apical Pacing Results in Better Overall Echocardiographic Outcomes than Non-Apical Right Ventricular Pacing (2008) (0)
reconstructive surgery Residual high incidence of ventricular arrhythmias after left ventricular (2013) (0)
Abstract 20108: Surgical Left Atrial Appendage Closure, Perioperative Outcomes and Long Term Mortality (2017) (0)
IMPROVEMENT IN EJECTION FRACTION PREDICTS SURVIVAL FOLLOWING CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH BOTH LEFT BUNDLE AND NON-LEFT BUNDLE BRANCH BLOCK MORPHOLOGIES (2012) (0)
Holter and Event Monitor Laboratory Setup (2020) (0)
Abstract 17259: Identification of Biological Pathways of Candidate Atrial Fibrillation Risk Genes Through the Use of Weighted Gene Coexpression Network Analysis (2020) (0)
B-PO02-107 INDICES OF CONTACT FORCE GUIDED CATHETER ABLATION AND PULMONARY VEIN RECONNECTION DURING REPEAT ATRIAL FIBRILLATION ABLATION PROCEDURES (2021) (0)
Response to Jeff S. Healey, MD, MSc and Michela Brambatti, MD. (2014) (0)
BS-515-03 ATRIAL FIBRILLATION ASSOCIATED COMMON INTRONIC RISK VARIANTS IN SYNE2 LEAD TO LOWER EXPRESSION OF NESPRIN-2A1, INCREASED NUCLEAR STIFFNESS AND EARLY AFTER DEPOLARIZATIONS IN CARDIOMYOCYTES (2022) (0)
Abstract 18458: A Simple Approach to Determine Risk Associated with Pacemaker and Implantable Cardioverter Defibrillator Replacements: The REPLACE Score (2010) (0)
Transvenous Lead Extraction in Patients with Prior Extraction Procedures: Procedural Profiles and Outcomes. (2020) (0)
Statin Therapy Impact on Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery (2015) (0)
1093-P: Association between First-Line Monotherapy with Metformin and the Risk of Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus (2020) (0)
Abstract 19937: Novel Advances in Radiographic Imaging Yield Important Reductions in Radiation Exposure (2016) (0)
P4-7: Left atrial connexin 43 expression, phosphorylation and distribution in human atrial fibrillation (2006) (0)
Abstract 13932: Implantable Cardioverter-Defibrillator FDA Safety Advisories Impact Patient Morbidity but Not Mortality (2011) (0)
Opportunities and challenges in heart rhythm research: Rationale and development of an electrophysiology collaboratory (2022) (0)
Syncope Management Facilities (2020) (0)
Incidence and Predictors of Postoperative Heart Failure in Patients Undergoing Elective Noncardiac Surgery (2010) (0)
Imaging in pacing and defibrillation (2007) (0)
Response to Letter Regarding "REPLACE DARE (Death After Replacement Evaluation) Score: Determinants of All-Cause Mortality After Implantable Device Replacement Or Upgrade From the REPLACE Registry". (2015) (0)
Cost effectiveness of implantable defibrillators following left ventricular reconstruction surgery in patients with ischemic cardiomyopathy (2003) (0)
Defibrillation thresholds in patients with implantable cardioverter defibrillator: Differences between dilated and ischemic cardiomyopathy (2005) (0)
Abstract 11462: Neurocognitive Function and Silent Cerebral Thromboemboli Following Atrial Fibrillation Catheter Ablation (2014) (0)
Abstract 110: Noncoding RNAs: A Possible "Linc" to Atrial Fibrillation (2012) (0)
B-type natriuretic peptide levels drop after ablation for atrial fibrillation (2005) (0)
Abstract 264: Assessing Thromboembolic Risk In Patients Undergoing Direct Electrical Cardioversion Within 48 Hours After Onset Of Atrial Fibrillation (2014) (0)
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes. (2022) (0)
Network-based prediction and functional validation of metformin for potential treatment of atrial fibrillation using human inducible pluripotent stem cell-derived atrial-like cardiomyocytes (2021) (0)
Catheter ablation of ventricular arrhythmias in nonischemic dilated cardiomyopathy patients (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mina K. Chung?

Mina K. Chung is affiliated with the following schools:

Mina K. Chung's Academic­Influence.com Rankings

Why Is Mina K. Chung Influential?

Mina K. Chung's Published Works

Published Works

What Schools Are Affiliated With Mina K. Chung?

Mina K. Chung's AcademicInfluence.com Rankings